Compare IRON & ALGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IRON | ALGT |
|---|---|---|
| Founded | 2017 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Air Freight/Delivery Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.9B |
| IPO Year | 2020 | 2006 |
| Metric | IRON | ALGT |
|---|---|---|
| Price | $80.94 | $81.63 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 10 |
| Target Price | ★ $103.18 | $97.30 |
| AVG Volume (30 Days) | 320.6K | ★ 511.7K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.62 |
| EPS | N/A | ★ 1.80 |
| Revenue | N/A | ★ $2,606,579,000.00 |
| Revenue This Year | N/A | $9.42 |
| Revenue Next Year | $283.52 | $6.52 |
| P/E Ratio | ★ N/A | $45.47 |
| Revenue Growth | N/A | ★ 3.74 |
| 52 Week Low | $40.00 | $57.11 |
| 52 Week High | $99.50 | $123.63 |
| Indicator | IRON | ALGT |
|---|---|---|
| Relative Strength Index (RSI) | 62.13 | 38.21 |
| Support Level | $70.73 | $72.44 |
| Resistance Level | $82.74 | $94.59 |
| Average True Range (ATR) | 2.94 | 4.63 |
| MACD | 0.05 | -1.01 |
| Stochastic Oscillator | 87.72 | 24.15 |
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
Allegiant Travel Co is a leisure travel company focused on providing travel and leisure services and products to residents of underserved cities in the United States. It operates a low-cost, low utilization passenger airline marketed to leisure travelers in underserved cities, allowing it to sell air transportation both on a stand-alone basis and bundled with the sale of air-related and third-party services and products. In addition, it provides air transportation under fixed-fee flight arrangements. In connection with its leisure travel focus, the company has opened Sunseeker Resort Charlotte Harbor, equipped with several guestrooms and food and beverage outlets. The company's operating segments are the Airline, which generates the maximum revenue, and Sunseeker Resort.